Biased and G protien-indepedent signalling of chemokine receptors

被引:145
作者
Steen, Anne [1 ]
Larsen, Olav [1 ]
Thiele, Stefanie [1 ]
Rosenkilde, Mette M. [1 ]
机构
[1] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark
关键词
7TM-receptor; 7TM structure-function; chemokine system; biased signaling; ligand/receptor/tissue bias; b-arrestin recruitment; G protein coupling; pathway-specific drug development; PROTEIN-COUPLED RECEPTOR; BICYCLAM NONPEPTIDE ANTAGONISTS; HIGH CONSTITUTIVE ACTIVITY; MULTIPLE CC-CHEMOKINES; HIGH-AFFINITY BINDING; BETA-ARRESTIN; SMALL-MOLECULE; CXC CHEMOKINES; NATURAL ANTAGONIST; DRY MOTIF;
D O I
10.3389/fimmu.2014.00277
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Biased signaling or functional selectivity occurs when a 7TM-receptor preferentially activates one of several available pathways. It can be divided into three distinct forms: ligand bias, receptor bias, and tissue or cell bias, where it is mediated by different ligands (on the same receptor), different receptors (with the same ligand), or different tissues or cells (for the same ligand-receptor pair). Most often biased signaling is differentiated into G protein-dependent and beta-arrestin-dependent signaling. Yet, it may also cover signaling differences within these groups. Moreover, it may not be absolute, i.e., full versus no activation. Here we discuss biased signaling in the chemokine system, including the structural basis for biased signaling in chemokine receptors, as well as in class A 7TM receptors in general. This includes overall helical movements and the contributions of micro-switches based on recently published 7TM crystals and molecular dynamics studies. All three forms of biased signaling are abundant in the chemokine system. This challenges our understanding of "classic" redundancy inevitably ascribed to this system, where multiple chemokines bind to the same receptor and where a single chemokine may bind to several receptors - in both cases with the same functional outcome. The ubiquitous biased signaling confers a hitherto unknown specificity to the chemokine system with a complex interaction pattern that is better described as promiscuous with context-defined roles and different functional outcomes in a ligand-, receptor-, or cell/tissue-defined manner. As the low number of successful drug development plans implies, there are great difficulties in targeting chemokine receptors; in particular with regard to receptor antagonists as anti-inflammatory drugs. Un-defined and putative non-selective targeting of the complete cellular signaling system could be the underlying cause of lack of success. Therefore, biased ligands could be the solution.
引用
收藏
页数:13
相关论文
共 145 条
[1]   CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B - Determinants of high affinity binding and receptor activitation are distinct [J].
Ahuja, SK ;
Lee, JC ;
Murphy, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :225-232
[2]  
AHUJA SK, 1993, J BIOL CHEM, V268, P20691
[3]   Current status of chemokine receptor inhibitors in development [J].
Allegretti, Marcello ;
Cesta, Maria Candida ;
Garin, Alexandre ;
Proudfoot, Amanda E. I. .
IMMUNOLOGY LETTERS, 2012, 145 (1-2) :68-78
[4]   Chemokine: Receptor structure, interactions, and antagonism [J].
Allen, Samantha J. ;
Crown, Susan E. ;
Handel, Tracy M. .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :787-820
[5]   Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B:: Evidence that directed migration is mediated by βγ dimers released by activation of Gαi-coupled receptors [J].
Arai, H ;
Tsou, CL ;
Charo, IF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14495-14499
[6]   Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [J].
Arvanitakis, L ;
GerasRaaka, E ;
Varma, A ;
Gershengorn, MC ;
Cesarman, E .
NATURE, 1997, 385 (6614) :347-350
[7]   International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors [J].
Bachelerie, Francoise ;
Ben-Baruch, Adit ;
Burkhardt, Amanda M. ;
Combadiere, Christophe ;
Farber, Joshua M. ;
Graham, Gerard J. ;
Horuk, Richard ;
Sparre-Ulrich, Alexander Hovard ;
Locati, Massimo ;
Luster, Andrew D. ;
Mantovani, Alberto ;
Matsushima, Kouji ;
Murphy, Philip M. ;
Nibbs, Robert ;
Nomiyama, Hisayuki ;
Power, Christine A. ;
Proudfoot, Amanda E. I. ;
Rosenkilde, Mette M. ;
Rot, Antal ;
Sozzani, Silvano ;
Thelen, Marcus ;
Yoshie, Osamu ;
Zlotnik, Albert .
PHARMACOLOGICAL REVIEWS, 2014, 66 (01) :1-79
[8]   The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J].
Balabanian, K ;
Lagane, B ;
Infantino, S ;
Chow, KYC ;
Harriague, J ;
Moepps, B ;
Arenzana-Seisdedos, F ;
Thelen, M ;
Bachelerie, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) :35760-35766
[9]  
Ballesteros J. A., 1995, Neuroscience Methods, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471]
[10]  
Bardi G, 2001, EUR J IMMUNOL, V31, P3291, DOI 10.1002/1521-4141(200111)31:11<3291::AID-IMMU3291>3.0.CO